OVID THERAPEUTICS INC's ticker is OVID and the CUSIP is 690469101. A total of 73 filers reported holding OVID THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 0.27 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $99,840 | +17.1% | 26,000 | 0.0% | 0.00% | – |
| Q2 2023 | $85,280 | +27.1% | 26,000 | 0.0% | 0.00% | – |
| Q1 2023 | $67,080 | +38.7% | 26,000 | 0.0% | 0.00% | – |
| Q4 2022 | $48,360 | +2.9% | 26,000 | 0.0% | 0.00% | – |
| Q3 2022 | $47,000 | -14.5% | 26,000 | 0.0% | 0.00% | – |
| Q2 2022 | $55,000 | -32.1% | 26,000 | 0.0% | 0.00% | – |
| Q1 2022 | $81,000 | +224.0% | 26,000 | +225.0% | 0.00% | – |
| Q4 2021 | $25,000 | -71.3% | 8,000 | -69.2% | 0.00% | – |
| Q3 2021 | $87,000 | -13.9% | 26,000 | 0.0% | 0.00% | – |
| Q2 2021 | $101,000 | +40.3% | 26,000 | +44.4% | 0.00% | – |
| Q1 2021 | $72,000 | +75.6% | 18,000 | 0.0% | 0.00% | – |
| Q4 2020 | $41,000 | -60.2% | 18,000 | 0.0% | 0.00% | -100.0% |
| Q3 2020 | $103,000 | -22.0% | 18,000 | 0.0% | 0.00% | 0.0% |
| Q2 2020 | $132,000 | +149.1% | 18,000 | 0.0% | 0.00% | – |
| Q1 2020 | $53,000 | -28.4% | 18,000 | 0.0% | 0.00% | – |
| Q4 2019 | $74,000 | +27.6% | 18,000 | 0.0% | 0.00% | – |
| Q3 2019 | $58,000 | – | 18,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TLS Advisors LLC | 1,380,346 | $3,516 | 18.08% |
| Madison Avenue Partners, LP | 3,104,603 | $8,009,876 | 1.72% |
| BVF INC/IL | 6,851,051 | $17,675,712 | 0.65% |
| CHI Advisors LLC | 864,822 | $2,231,241 | 0.59% |
| EcoR1 Capital, LLC | 6,117,400 | $15,782,892 | 0.51% |
| Rubric Capital Management LP | 7,001,124 | $18,062,900 | 0.47% |
| Artal Group S.A. | 2,500,000 | $6,450 | 0.38% |
| Tejara Capital Ltd | 118,791 | $306,481 | 0.16% |
| DCF Advisers, LLC | 68,264 | $176,120 | 0.11% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 827,580 | $2,135,156 | 0.06% |